AMPK Signaling Pathway as a Potential Therapeutic Target for Parkinson's Disease
Parkinson's disease (PD) is the second most common neurodegenerative disease caused by the loss of dopaminergic neurons. Genetic factors, inflammatory responses, oxidative stress, metabolic disorders, cytotoxic factors, and mitochondrial dysfunction are all involved in neuronal death in neurode...
Saved in:
Main Authors: | Seyed Zanyar Athari (Author), Fereshteh Farajdokht (Author), Rana Keyhanmanesh (Author), Gisou Mohaddes (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson's Disease
by: Manuj Ahuja, et al.
Published: (2022) -
Ghrelin Increases Lymphocytes in Chronic Normobaric Hypoxia
by: Fariba Mirzaie Bavil, et al.
Published: (2014) -
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease
by: Yumin Wang, et al.
Published: (2021) -
Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease
by: Victor Tapias, et al.
Published: (2023) -
Therapeutic Potential of Targeting the PERK Signaling Pathway in Ischemic Stroke
by: Xinyuan Yu, et al.
Published: (2024)